Publications Database

Campbell M. et al. (1990)

Stereotypies and tardive dyskinesia: abnormal movements in autistic children.

Psychopharmacology Bulletin

26(2), pp. 260-266

Read Abstract (New Window)

Ernst M. et al. (1993)

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.

Psychopharmacology Bulletin

29(2), pp. 221-227

Read Abstract (New Window)

Locascio J. et al. (1991)

Factors related to haloperidol response and dyskinesias in autistic children.

Psychopharmacology Bulletin

27(2), pp. 119-126

Malone R. P. , Harvey J. A. (2008)

Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 221-222

Read Extract (New Window)

Malone R. P. (2008)

Can antipsychotic medication help my child?

Baltimore, MD: Interactive Autism Network

Read Full (New Window)

Malone R. P. et al. (2001)

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.

Journal of the American Academy of Child and Adolescent Psychiatry

40 pp. 887-894.

Read Abstract (New Window)

Malone R. P. et al. (1991)

Repeated episodes of neuroleptic-related dyskinesias in autistic children.

Psychopharmacology Bulletin

27(2), pp. 113-117

Read Abstract (New Window)

Malone R. P. et al. (2002)

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.

Journal of the American Academy of Child and Adolescent Psychiatry

41(2), pp. 140-147

Read Abstract (New Window)

Malone R. P. , Waheed A. (2009)

The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism.

Drugs

69(5), pp. 535-548.

Read Abstract (New Window)

Malone R. P. et al. (2007)

Ziprasidone in adolescents with autism: an open-label pilot study.

Journal of Child and Adolescent Psychopharmacology

17(6), pp. 779-790

Read Abstract (New Window)

Silva R. R. et al. (1993)

Haloperidol withdrawal and weight changes in autistic children.

Psychopharmacology Bulletin

29(2), pp. 287-291

Read Abstract (New Window)